Pemetrexed

Pharm Company: * APP PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Pemetrexed Overview

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer. Contents 1 Medical use 1.1 Carboplatin 1.2 Supplementation 2 Side effects 3 Mechanism of action 4 History 5 Society and culture 5.1 Trade names 5.2 Cost 6 References 7 External links Medical use In February 2004, the Food and Drug Administration approved pemetrexed for treatment of mal...

Read more Pemetrexed Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pemetrexed

Recent Pemetrexed Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pemetrexed
  • Injection: 100mg, 100mg/1vile, 100mg/vial, 1g, 500mg, 500mg/vial
  • Powder: 100mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pemetrexed or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA